tsn

Do COVID-19 Vaccines Link to Oncogenesis? 3/4 Reviewers Accept but Frontiers in Oncology Reject Manuscript

 566
5 comments
Staff at TrialSite | Quality Journalism
Sep. 29, 2023, 1:00 p.m.

A recent paper uploaded to the Authorea preprint server, involves the possibility that COVID-19 mRNA vaccines could trigger changes leading to oncogenesis. Led by Rachel Valdes Angues, a senior researcher and Post Doc at Oregon Health and Science University (OHSU), and researcher Yolanda Perea Bustos, the pair point to a hypothesis for COVID-19 vaccines and oncogenesis, also known as tumorigenesis or carcinogenesis, a phenomenon referring to the process by which normal cells are transformed into cancer cells. This process represents one that is complex, and multistep, one that involves various genetic, epigenetic, and environmental factors. Overall, oncogenesis leads to the development and progression of cancer. The pair express a disturbing hypothesis, one that’s based on reviews of the medical literature: that COVID-19 vaccines may predispose some cancer patients to cancer progression, recurrence, and/or metastasis.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News